TLOG (TetraLogic Pharmaceuticals) Effective Interest Rate on Debt %: 23.17% (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Effective Interest Rate on Debt %?

TetraLogic Pharmaceuticals TLOG Effective Interest Rate on Debt % is 23.17% as of Sep. 2016.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. TetraLogic Pharmaceuticals's annualized positive value of Interest Expense for the quarter that ended in Sep. 2016 was $7.04 Mil. TetraLogic Pharmaceuticals's average total debt for the quarter that ended in Sep. 2016 was $30.37 Mil. Therefore, TetraLogic Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2016 was 23.17%.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

TetraLogic Pharmaceuticals Effective Interest Rate on Debt % Related Terms

TetraLogic Pharmaceuticals Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Effective Interest Rate on Debt % Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Effective Interest Rate on Debt %
0.00 1.53 58.18 12.30 22.97

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.55 23.01 23.42 23.29 23.17

TLOG vs ARGSQ, GTHR, SOAN: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, TetraLogic Pharmaceuticals's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TetraLogic Pharmaceuticals Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TetraLogic Pharmaceuticals's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where TetraLogic Pharmaceuticals's Effective Interest Rate on Debt % falls into.


TetraLogic Pharmaceuticals Effective Interest Rate on Debt % Calculation

TetraLogic Pharmaceuticals's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2015 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2014 )+Total Debt  (A: Dec. 2015 ))/ count )
=-1  *  -6.384/( (27.304+28.279)/ 2 )
=-1  *  -6.384/27.7915
=22.97 %

where

Total Debt  (A: Dec. 2014 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=27.304 + 0
=27.304

Total Debt  (A: Dec. 2015 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=28.279 + 0
=28.279

TetraLogic Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2016 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2016 )+Total Debt  (Q: Sep. 2016 ))/ count )
=-1  *  -7.036/( (29.925+30.809)/ 2 )
=-1  *  -7.036/30.367
=23.17 %

where

Total Debt  (Q: Jun. 2016 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=29.925 + 0
=29.925

Total Debt  (Q: Sep. 2016 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=30.809 + 0
=30.809

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2016) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 23.17% mean?
TetraLogic Pharmaceuticals (TLOG) has a Effective Interest Rate on Debt % of 23.17% as of Sep. 2016. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Effective Interest Rate on Debt % too high?
TetraLogic Pharmaceuticals' current Effective Interest Rate on Debt % is 23.17%.
How does TetraLogic Pharmaceuticals' Effective Interest Rate on Debt % compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Effective Interest Rate on Debt % of 23.17% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Effective Interest Rate on Debt % is 23.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Effective Interest Rate on Debt % of 23.17%. The current Effective Interest Rate on Debt % is 23.17%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Effective Interest Rate on Debt % is 23.17% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.